FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014964241> ?p ?o ?g. }

• W2014964241 endingPage "201" @default.
• W2014964241 startingPage "195" @default.
• W2014964241 abstract "Measurement of blood pressure in the clinic may provide a false impression of blood pressure control. Ambulatory blood pressure monitoring (ABPM) allows the automatic recording of the circadian variation in blood pressure and evaluation of the efficacy of antihypertensive medication throughout the dosing interval. Ambulatory blood pressure provides more effective prediction of cardiovascular risk; blood pressure control at the time of heightened risk in the early morning after waking and before taking the next dose of medication is becoming important in order to improve long-term prognosis. To achieve blood pressure control in the early morning, a long-acting antihypertensive agent is essential. Telmisartan, an angiotensin II receptor blocker, as well as having a terminal elimination half-life of 24 h, has a large volume of distribution due to its high lipophilicity. The efficacy of telmisartan 80 mg monotherapy has been demonstrated using ABPM, with superior reduction in mean values for the last 6 h of the dosing interval compared with ramipril 10 mg and valsartan 80 mg. In addition, telmisartan 80 mg provides superior blood pressure control after a missed dose compared with valsartan 160mg. When combined with hydrochlorothiazide (HCTZ) 12.5 mg, telmisartan 40mg and 80mg is more effective than losartan/HCTZ (50/12.5 mg) at the end of the dosing interval. Furthermore, greater reductions in last 6 h mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) are achieved with telmisartan/HCTZ (80/12.5 mg) than with valsartan/HCTZ (160/12.5 mg) in obese patients with type 2 diabetes and hypertension. Recent data from a large group of patients show that telmisartan 80 mg controls the early morning blood pressure surge more effectively than ramipril 5-10 mg and, thus, may have a greater beneficial effect on long-term cardiovascular risk. This supposition is being tested in the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET) programme." @default.
• W2014964241 created "2016-06-24" @default.
• W2014964241 creator A5056706626 @default.
• W2014964241 date "2006-08-01" @default.
• W2014964241 modified "2023-10-10" @default.
• W2014964241 title "A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours" @default.
• W2014964241 cites W104612557 @default.
• W2014964241 cites W168864114 @default.
• W2014964241 cites W1964044304 @default.
• W2014964241 cites W1965573335 @default.
• W2014964241 cites W1966152099 @default.
• W2014964241 cites W1966188750 @default.
• W2014964241 cites W1984571776 @default.
• W2014964241 cites W1994696430 @default.
• W2014964241 cites W1996417344 @default.
• W2014964241 cites W2007701939 @default.
• W2014964241 cites W2011522985 @default.
• W2014964241 cites W2021784922 @default.
• W2014964241 cites W2025821976 @default.
• W2014964241 cites W2026271802 @default.
• W2014964241 cites W2031335602 @default.
• W2014964241 cites W2040440698 @default.
• W2014964241 cites W2040593120 @default.
• W2014964241 cites W2046575388 @default.
• W2014964241 cites W2046584811 @default.
• W2014964241 cites W2047357959 @default.
• W2014964241 cites W2051801861 @default.
• W2014964241 cites W2052331738 @default.
• W2014964241 cites W2055557968 @default.
• W2014964241 cites W2057850517 @default.
• W2014964241 cites W2064016507 @default.
• W2014964241 cites W2078725437 @default.
• W2014964241 cites W2080742733 @default.
• W2014964241 cites W2089889539 @default.
• W2014964241 cites W2090154587 @default.
• W2014964241 cites W2090314376 @default.
• W2014964241 cites W2092339133 @default.
• W2014964241 cites W2093767212 @default.
• W2014964241 cites W2094899777 @default.
• W2014964241 cites W2110792462 @default.
• W2014964241 cites W2113140933 @default.
• W2014964241 cites W2130538300 @default.
• W2014964241 cites W2137704829 @default.
• W2014964241 cites W2143033551 @default.
• W2014964241 cites W2144375073 @default.
• W2014964241 cites W2153034914 @default.
• W2014964241 cites W2153553951 @default.
• W2014964241 cites W2156121263 @default.
• W2014964241 cites W2157761720 @default.
• W2014964241 cites W2171903673 @default.
• W2014964241 cites W2313938778 @default.
• W2014964241 cites W2316116511 @default.
• W2014964241 cites W2328082272 @default.
• W2014964241 cites W2331449009 @default.
• W2014964241 cites W2396772514 @default.
• W2014964241 cites W2411020299 @default.
• W2014964241 cites W2419574750 @default.
• W2014964241 cites W24673211 @default.
• W2014964241 cites W2470559383 @default.
• W2014964241 cites W2977629971 @default.
• W2014964241 cites W4229507647 @default.
• W2014964241 cites W4246169631 @default.
• W2014964241 cites W4300670116 @default.
• W2014964241 cites W4376595320 @default.
• W2014964241 cites W49926788 @default.
• W2014964241 cites W75245760 @default.
• W2014964241 cites W7687383 @default.
• W2014964241 doi "https://doi.org/10.2147/vhrm.2006.2.3.195" @default.
• W2014964241 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1993985" @default.
• W2014964241 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17326326" @default.
• W2014964241 hasPublicationYear "2006" @default.
• W2014964241 type Work @default.
• W2014964241 sameAs 2014964241 @default.
• W2014964241 citedByCount "36" @default.
• W2014964241 countsByYear W20149642412012 @default.
• W2014964241 countsByYear W20149642412013 @default.
• W2014964241 countsByYear W20149642412016 @default.
• W2014964241 countsByYear W20149642412017 @default.
• W2014964241 countsByYear W20149642412018 @default.
• W2014964241 countsByYear W20149642412019 @default.
• W2014964241 countsByYear W20149642412020 @default.
• W2014964241 countsByYear W20149642412021 @default.
• W2014964241 countsByYear W20149642412022 @default.
• W2014964241 countsByYear W20149642412023 @default.
• W2014964241 crossrefType "journal-article" @default.
• W2014964241 hasAuthorship W2014964241A5056706626 @default.
• W2014964241 hasBestOaLocation W20149642412 @default.
• W2014964241 hasConcept C126322002 @default.
• W2014964241 hasConcept C149323552 @default.
• W2014964241 hasConcept C164705383 @default.
• W2014964241 hasConcept C19720800 @default.
• W2014964241 hasConcept C2777387769 @default.
• W2014964241 hasConcept C2779716603 @default.
• W2014964241 hasConcept C2779888176 @default.
• W2014964241 hasConcept C2780288358 @default.
• W2014964241 hasConcept C2780361556 @default.
• W2014964241 hasConcept C2908929049 @default.
• W2014964241 hasConcept C71924100 @default.

• next